R&D Systems understands the critical nature of having a stable supply chain of Good Manufacturing Practices (GMP)-grade Proteins used as raw materials in the manufacturing of advanced therapies. This becomes progressively more important with the increased need that accompanies the transition from early stage to later stage clinical trials. We will work closely with you on forecasting, and in the development of supply and quality agreements, to provide consistent access to the high-quality GMP proteins you require.
Part of our commitment includes an openness about any changes made to manufacturing processes. If a rare change does occur, you will be notified and we will work with you to determine whether the change will impact your process. We are committed to assisting in the transition to the latest material, or ensuring the original material continues to be made available if necessary.